Angela Ballantyne teaches medical ethics at the University of Otago, Wellington.  Her research interests include research with human subjects, justice, vulnerability, reproductive technologies, and data ethics. She has served on national expert committees for covid immunisation policy and research ethics review and is currently on the National AI and Algorithm Expert Advisory Group and the Ethics Committee on Assisted Reproductive Technologies in Aotearoa New Zealand. She has been President of the International Association of Bioethics; has worked in global health policy and ethics at the World Health Organization in Geneva, and is a regular Visiting Scholar at Yale University and the National University of Singapore.

Tony is an epidemiologist and public health medicine specialist. He is committed to answering questions about which public health interventions will achieve the greatest improvements in health and social outcomes, reduce inequalities in health, and do so cost-effectively.

​

His research covers a range of topic areas, intersected with methodological advancements. Whilst principally an epidemiologist, he uses and combines methods from multiple disciplines: biostatistics, economics, econometrics, and computer and data science.

​

Tony is Director of the Population Interventions (PI) Unit within the Centre for Epidemiology and Biostatistics at the Melbourne School of Population and Global Health. PI aims to: "provide robust evidence on the health and cost impacts of population interventions, through causal inference and simulation approaches from epidemiology, economics and data science." As part of the PI Unit, Tony is leading the Scalable Health Intervention Evaluation program - SHINE - which is a data science and simulation platform to rapidly estimate health, health inequality, cost and productivity impacts of virtually any preventive intervention, in any country.

Tony moved to Australia, and the University of Melbourne, in 2019. From 1998 to 2018 he was based at the University of Otago, Wellington New Zealand. From 2023 to 2024 Tony is Chair of the New Zealand

​

Royal Commission on COVID-19 Lessons Learned.

​

Matthew Fox, DSc, MPH, is a Professor in the Departments of Epidemiology and Global Health at Boston University. Dr. Fox joined Boston University in 1999. His research interests include treatment outcomes in HIV-treatment programs, infectious disease epidemiology (with specific interests in HIV and pneumonia), and epidemiologic methods. Dr. Fox works on ways to improve retention in HIV-care programs in South Africa from the time of testing HIV-positive through long-term treatment. As part of this work, he is involved in analyses to assess the impact of changes in South Africa’s National Treatment Guidelines for HIV. Dr. Fox also does research on quantitative bias analysis and co-authored a book on these methods, Applying Quantitative Bias Analysis to Epidemiologic Data (http://www.springer.com/public+health/book/978-0-387-87960-4). He is also the host of a public health journal club podcast called Free Associations designed to help people stay current in the public health literature and think critically about the quality of research studies (https://bit.ly/30fPApj) and a podcast on Epidemiologic Methods called SERious Epi (https://seriousepi.blubrry.net/). He currently teaches a third-level epidemiologic methods class, Advanced Epidemiology as well as two other doctoral level epidemiologic methods courses. Dr. Fox is a graduate of the Boston University School of Public Health with a master’s degree in epidemiology and biostatistics and a doctorate in epidemiology.

​

Professor Paul Kelly is currently the Chief Medical Officer and Head of Interim Australian Centre for Disease Control at the Australian Government Department of Health and Aged Care. A public health physician and epidemiologist by training, Professor Kelly was the principal medical advisor to the Australian Government during the COVID-19 pandemic

​

Professor Kelly has previously worked in research, health systems development, post-graduate teaching and as a health service executive at local, state and national level in Australia, Malawi, Indonesia, East Timor and the UK. 

Professor Kelly has over 30 years research experience and has published over 200 journal articles, book chapters and public health guidelines. He has supervised or mentored many trainees and post-graduate students and delivered lectures, workshops, seminars and conference talks in Australia and internationally on a range of health related topics.

​

David Muscatello is an Associate Professor in infectious diseases epidemiology. He has a PhD in the epidemiology of pandemic and seasonal influenza. He also has many years' experience in government as an epidemiologist specialising in acute disease surveillance using administrative databases and linked data, public health intelligence and biostatistics including time series analysis. He served in the New South Wales government response to both the COVID-19 and 2009 influenza pandemics and has served on the Australian National Influenza Surveillance Committee. David is also a graduate of the New South Wales Public Health Officer Training Program and has supervised and trained numerous Public Health Officer and Biostatistical trainees. He is particularly interested in the use of time series analysis for estimating mortality and morbidity from infectious and other diseases and for assessing the impact of health policies on populations. He contributes to the World Health Organization's (WHO) activities for pandemic severity assessment and estimating the global burden of deaths and hospitalisations attributable to influenza.

​

Dr. Alpa V. Patel earned her Bachelor of Science from the University of Florida, her Master of Public Health in Epidemiology from the Rollins School of Public Health at Emory University, and her Doctoral degree in Preventive Medicine with a concentration in Epidemiology from the Keck School of Medicine at the University of Southern California. She has been with the American Cancer Society for more than 25 years and is the Senior Vice President of Population Science at the American Cancer Society where she oversees a team of approximately 55 research and study operations staff. She serves as the principal investigator of the Cancer Prevention Studies (CPS) II and 3 that are long-term, large-scale, epidemiologic cohort studies established by the American Cancer Society. Combined, these two cohorts include over 1.5 million participants with a variety of over 400,000 biologic samples (such as blood, buccal cells, saliva, stool, and tumor tissue). Recently, as the co-Principal Investigator, Dr. Patel and team launched the largest ever cancer cohort of Black women in the U.S. aimed to enroll at least 100,000 Black women to understand the multi-level drivers of cancer risk and outcomes in this population. Dr. Patel is a recognized leader in cancer epidemiology with particular emphases on the role of physical inactivity, obesity, sedentary behavior and cancer as well as blood-based markers of cancer detection. She serves on the National Cancer Institute’s Board of Scientific Counselors along with several other national and international scientific advisory committees. She has published over 250 scientific articles and book chapters, and her research has contributed significantly to national and international cancer prevention guidelines, such as the US Physical Activity Guidelines for Health and the American Cancer Society’s Nutrition and Physical Activity Guidelines for both cancer prevention and cancer survivorship.  

​

Dr Stacey Rowe is an infectious diseases epidemiologist, Postdoctoral Fellow at the University of San Francisco (United States), and Adjunct Senior Research Fellow at Monash University (Australia).

​

She has more than 15 years’ experience in overseeing population-wide communicable disease surveillance and epidemiology programs in Victoria, Australia. Between 2020 and 2023, Dr Rowe was Director, Data and Intelligence as part of Victoria’s State Government response to the COVID-19 pandemic. She completed her PhD with Monash University in 2023, which focussed on the use of linked data to support communicable surveillance and control.

Dr Rowe is currently a lead contributor to an NIH-funded research program examining the uptake, safety and effectiveness of COVID-19 vaccines during pregnancy.

​